Skip to main content

Polycomb in the prostate

Prostate cancer becomes fatal when associated with metastasis. In the October 10 Nature, Varambally et al. describe a microarray-based analysis of genes whose expression is altered in metastatic prostate cancer (Nature 2002, 419:624-629). They identified 55 genes that were upregulated in metastatic tumors relative to localized ones, and found that the gene encoding the polycomb-group protein Enhancer of zeste homolog 2 (EZH2) was significantly upregulated in metastatic cells and correlated with cancer progression. Disruption of EZH2expression by RNAi caused growth inhibition and growth arrest at the G2- to M-phase transition in the cell cycle. Overexpression of EZH2 in cancer cells caused repression of a subset of genes, and this required the EZH2 'SET' domain and endogenous histone deacetylase activity.

References

  1. 1.

    Delineation of prognostic biomarkers in prostate cancer.

  2. 2.

    Nature, [http://www.nature.com]

  3. 3.

    Polycomb group protein complexes: do different complexes regulate distinct target genes?

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weitzman, J.B. Polycomb in the prostate. Genome Biol 3, spotlight-20021017-01 (2002). https://doi.org/10.1186/gb-spotlight-20021017-01

Download citation

Keywords

  • Cancer Cell
  • Cell Cycle
  • Prostate Cancer
  • Metastatic Tumor
  • Growth Inhibition